You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SARS-CoV2; Cannabidiol

Showing 1 - 25 of 5,823
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COVID-19, SAR Trial in Hanover (CBDRA60 supplement, Placebo)

Not yet recruiting
  • COVID-19
  • SAR
  • CBDRA60 supplement
  • Placebo
  • Hanover, Michigan
    Anewsha Therapeutics / Comco R&D
Feb 18, 2022

SARS-CoV2 Trial in Ribeirão Preto (Cannabidiol, PLACEBO)

Active, not recruiting
  • SARS-CoV2
  • Ribeirão Preto, SP, Brazil
  • +1 more
Sep 27, 2021

Awake Prone Positioning in COVID-19 ICU Patients

Not yet recruiting
  • SARS-CoV 2 Pneumonia
  • quality of life questionnaire
  • Tours, France
    university hospital Tours
Oct 10, 2023

Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in

Not yet recruiting
  • Systemic Sclerosis
  • SARS-CoV 2 Vaccination
    • (no location specified)
    Jul 24, 2023

    Covid19 Trial in Cypress (VXA-CoV2-1)

    Completed
    • Covid19
    • VXA-CoV2-1
    • Cypress, California
      WCCT
    Jan 17, 2023

    SARS-CoV2 Infection Trial in Flint (General SARS-CoV-2 Communication, Rural-Targeted SARS-CoV-2 Communication)

    Recruiting
    • SARS-CoV2 Infection
    • General SARS-CoV-2 Communication
    • Rural-Targeted SARS-CoV-2 Communication
    • Flint, Michigan
      Flint Journal Building
    Oct 10, 2023

    SARS-CoV-2 Virus Trial in Bangkok (SARS-CoV-2 RNA detection)

    Completed
    • SARS-CoV-2 Virus
    • SARS-CoV-2 RNA detection
    • Bangkok, Thailand
      2 Division of Nephrology,Department of Medicine Pramongkutklao H
    Aug 31, 2023

    SARS-CoV-2 Trial in Nanjing (SARS-CoV-2 Bivalent mRNA Vaccine, Recombinant SARS-CoV-2 vaccine, Saline)

    Not yet recruiting
    • SARS-CoV-2
    • SARS-CoV-2 Bivalent mRNA Vaccine
    • +2 more
    • Nanjing, Jiangsu, China
      Jiangsu Provincial Center for Disease Control and Prevention
    Jul 7, 2023

    SARS-CoV-2 Infection, Varicella, Measles Trial in Shanghai (Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine,

    Not yet recruiting
    • SARS-CoV-2 Infection
    • +4 more
    • Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine
    • +2 more
    • Shanghai, Shanghai, China
      Shanghai Municipal Center for Disease Control and Prevention
    Jul 17, 2023

    a Randomized Double-blind Study, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), PHYTOTHERAPIE Trial in Sahloul

    Completed
    • a Randomized Double-blind Study
    • +2 more
    • Sahloul, Sousse, Tunisia
      Riadh Boukef
    Jan 2, 2023

    SARS-CoV-2 Trial in Nanjing (SARS-CoV-2 Bivalent mRNA Vaccine, Saline)

    Not yet recruiting
    • SARS-CoV-2
    • SARS-CoV-2 Bivalent mRNA Vaccine
    • Saline
    • Nanjing, Jiangsu, China
      Jiangsu Provincial Center for Disease Control and Prevention
    Jul 7, 2023

    SARS-COV2 Pandemic Serosurvey in a Rare Disease Population

    Completed
    • SARS-COV2 Virus
      • Bethesda, Maryland
      • +1 more
      Dec 16, 2022

      SARS-CoV-2 Trial in Chengdu (SARS-CoV-2 mRNA vaccine (RBMRNA), CoronaVac®)

      Active, not recruiting
      • SARS-CoV-2
      • SARS-CoV-2 mRNA vaccine (RBMRNA)
      • CoronaVac®
      • Chengdu, Sichuan, China
        Chengdu Xinhua Hospital affiliated to North Sichuan Medical Coll
      Jun 12, 2023

      LumiraDX SARS-CoV-2 Ag Ultra and LumiraDX SARS-CoV-2 & Flu A/B

      Not yet recruiting
      • SARS-CoV-2
      • +4 more
      • LumiraDx SARS-CoV-2 Ag Ultra
      • LumiraDx SARS-CoV-2 & Flu A/B
      • DeLand, Florida
        Hillcrest Medical Research
      Feb 6, 2023

      COVID-19 Trial (NVX-CoV2601 co-formulated Omicron XBB.1.5 SARS-CoV-2 rS vaccine, Prototype/XBB.1.5 Bivalent Vaccine (5 µg))

      Not yet recruiting
      • COVID-19
      • NVX-CoV2601 co-formulated Omicron XBB.1.5 SARS-CoV-2 rS vaccine
      • Prototype/XBB.1.5 Bivalent Vaccine (5 µg)
      • (no location specified)
      Aug 4, 2023

      SARS-CoV-2 Vaccination on Cancer Patients Infected With

      Recruiting
      • COVID-19 Infection
      • COVID-19 Vaccine
      • no intervention
      • Beijing, Beijing, China
        Sanhuan Cancer Hospital, Chaoyang District, Beijing(Cancer Hospi
      Mar 7, 2023

      SARS-CoV-2 Trial in Islamabad (SARS-CoV-2 Bivalent mRNA vaccine (LVRNA021), 0.9% sodium chloride solution)

      Recruiting
      • SARS-CoV-2
      • SARS-CoV-2 Bivalent mRNA vaccine (LVRNA021)
      • 0.9% sodium chloride solution
      • Islamabad, Pakistan
        Sindh Infectious Diseases Hospital & Research Center Dow Univers
      Apr 16, 2023

      COVID-19 Trial in Guangzhou (the recombinant SARS-CoV-2 S-Trimer vaccine/inactivated SARS-CoV-2 vaccine)

      Recruiting
      • COVID-19
      • the recombinant SARS-CoV-2 S-Trimer vaccine/inactivated SARS-CoV-2 vaccine
      • Guangzhou, Guangzhou, China
        The Fifth Affiliated Hospital of Guangzhou Medical University
      Jan 28, 2023

      Lipids in SARS-CoV2 Infection - In Search of Atherogenic

      Recruiting
      • SARS-CoV2 Infection
      • Blood sample of 30 ml
      • Dijon, France
        Chu Dijon Bourgogne
      Jul 25, 2022

      Immunogenicity, Safety Trial (Phase II:SWIM816;SARS-Cov-2;, Phase II:SW-BIC-213;SARS-Cov-2;, PhaseIII:SWIM816;SARS-Cov-2;)

      Not yet recruiting
      • Immunogenicity
      • Safety
      • Phase II:SWIM816;SARS-Cov-2;
      • +3 more
      • (no location specified)
      Jun 18, 2023

      Vitamin D and Vitamin D Binding Protein With Disease Severity in

      Active, not recruiting
      • SARS CoV-2 Infection
      • Vitamin D Binding protein
      • Istanbul, Turkey
        Haseki Training and Research Hospital
      Nov 1, 2022

      Respiratory Viral Infection Trial (SARS-COV-2, Influenza and RSV 8-Well MT-PCR Panel, BioFire Respiratory Panel 2.1)

      Not yet recruiting
      • Respiratory Viral Infection
      • SARS-COV-2, Influenza and RSV 8-Well MT-PCR Panel
      • BioFire Respiratory Panel 2.1
      • (no location specified)
      Jul 13, 2023

      SARS-CoV-2 Infection, COVID-19, Coronavirus Trial in Marseille, Nîmes (eBAM Cov Testing)

      Not yet recruiting
      • SARS-CoV-2 Infection
      • +2 more
      • eBAM Cov Testing
      • Marseille, France
      • +1 more
      Oct 23, 2023

      Sars-Covid-19 Vaccines in Haematological Patients: Prospective

      Completed
      • Hematologic Diseases
      • IgG antibodies to Sars-Cov-2
      • QuantiFERON SARS-CoV-2 test
      • Monza, Lombardia, Italy
        San Gerardo Hospital
      Jan 23, 2023

      Influenza A, Influenza Type B, SARS CoV 2 Infection Trial in Raleigh (Diagnostic Test for identification of influenzas A,

      Not yet recruiting
      • Influenza A
      • +3 more
      • Diagnostic Test for identification of influenzas A, influenzas B, RSV and SARS-CoV-2 infections
      • Raleigh, North Carolina
        Wake Med
      Jun 26, 2023